Search Results - "Calori, E"

Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies by Catani, L, Gugliotta, L, Mattioli Belmonte, M, Vianelli, N, Gherlinzoni, F, Miggiano, M C, Belardinelli, A R, Rosti, G, Calori, E, Bandini, G

“…Severe thrombotic alterations, such as veno-occlusive disease of the liver, may occur in the early phase following high-dose chemoradiotherapy and BMT. In this…”
Get more information

Toxicity of high-dose busulphan and cyclophosphamide as conditioning therapy for allogeneic bone marrow transplantation in adults with haematological malignancies by Bandini, G, Belardinelli, A, Rosti, G, Calori, E, Motta, M R, Rizzi, S, Benini, C, Tura, S

“…The toxicity of the conditioning regimen high-dose busulfan (BU) 16 mg/kg followed by cyclophosphamide (CY) 200 mg/kg has been analysed in 60 adult patients…”
Get more information

In vitro amplification of hypervariable DNA regions for the evaluation of chimerism after allogeneic BMT by Martinelli, G, Trabetti, E, Zaccaria, A, Farabegoli, P, Buzzi, M, Testoni, N, Calori, E, Bandini, G, Rosti, G, Belardinelli, A

“…The role of mixed hematopoietic chimerism in engraftment and relapse after allogeneic BMT remains unclear. To better evaluate post-transplant chimerism we used…”
Get more information

Acute myeloid leukemia from diagnosis to bone marrow transplantation: experience from a single centre by Gamberi, B, Bandini, G, Visani, G, Rosti, G, Cenacchi, A, Motta, M R, Fruet, F, Calori, E, Rizzi, S, Tosi, P

“…We analysed the use of allogeneic bone marrow transplantation (BMT) in the treatment of acute myelogenous leukemia (AML). We evaluated 271 adult patients with…”
Get more information

Autologous bone marrow transplantation with marrow cryopreserved for ten years by Motta, M R, Benini, C, Bandini, G, Gherlinzoni, F, Miggiano, M C, Calori, E, Lemoli, R M, Tura, S

Get more information

Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3 by Anasetti, C, Martin, P J, Storb, R, Appelbaum, F R, Beatty, P G, Calori, E, Davis, J, Doney, K, Reichert, T, Stewart, P

“…The efficacy of murine monoclonal IgG1 antibody 2A3 specific for the 55 kD chain of the human IL-2 receptor (CD25) was evaluated for prophylaxis of acute GVHD…”
Get more information

Donor origin of hematopoiesis after a case of allogeneic transplantation with cryopreserved marrow by Benini, C, Bandini, G, Motta, M R, Belardinelli, A R, Calori, E, Rizzi, S, Martinelli, G, Rosti, G, Trabetti, E, Pignatti, P

“…In allogeneic marrow transplantation (BMT), fresh donor marrow is generally given like a simple transfusion immediately after collection. Cryopreservation, on…”
Get more information

Pharmacokinetics of high-dose cyclophosphamide for bone marrow transplantation by Fasola, G, Lo Greco, P, Calori, E, Zilli, M, Verlicchi, F, Motta, M R, Ricci, P, Baccarani, M, Tura, S

“…Despite the fact that high-dose cyclophosphamide (CP) is currently used for both cancer treatment and bone marrow transplantation, its pharmacokinetics is not…”
Get more information

New strategies for selection of unrelated bone marrow donors by Martinelli, G, Buzzi, M, Farabegoli, P, Testoni, N, Mantovani, V, Calori, E, Rosti, G, Bandini, G, Bragliani, M, Panzica, G

“…An important problem in the selection of unrelated donors for bone marrow transplantation (UD-BMT), is HLA matching, between selected donor and recipient…”
Get more information

Fingerprinting of HLA class I genes for improved selection of unrelated bone marrow donors by Martinelli, G, Farabegoli, P, Buzzi, M, Panzica, G, Zaccaria, A, Bandini, G, Calori, E, Testoni, N, Rosti, G, Conte, R, Remiddi, C, Salvucci, M, De Vivo, A, Tura, S

“…The degree of matching of HLA genes between the selected donor and recipient is an important aspect of the selection of unrelated donors for allogeneic bone…”
Get more information

Autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma: comparison of different parameters in predicting the kinetics of haematological recovery by Visani, G, Dinota, A, Verlicchi, F, Bandini, G, Ricci, P, Motta, M R, Rizzi, S, Lemoli, R M, Poluzzi, C, Gherlinzoni, F

“…We analysed the kinetics of haematological recovery after autologous bone marrow transplantation (ABMT) in 31 patients with non-Hodgkin's lymphoma, of whom 14…”
Get more information

Systemic broad-spectrum antimicrobial prophylaxis in hematological patients after intensive antineoplastic chemotherapy by Verlicchi, F, Ricci, P, Bassi, A, Benfenati, D, Bandini, G, Rosti, G, Calori, E, Borghi, C, Tura, S

“…We performed a pilot study on 13 heavily treated hematologic patients, in whom a systemic broad-spectrum antimicrobial prophylaxis was started after the end of…”
Get more information

Alteplase for hepatic veno-occlusive disease after bone-marrow transplantation by Rosti, G, Bandini, G, Belardinelli, A, Calori, E, Tura, S, Gherlinzoni, F, Miggiano, C

Get more information

Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome by Bandini, G, Rosti, G, Calori, E, Albertazzi, L, Tura, S

Get more information

Bone marrow transplantation from unrelated donors: the Italian experience. GITMO, AIEOP and IBMDR by Lanino, E, Lamparelli, T, Dini, G, Alessandrino, E P, Aversa, F, Calori, E, Medugno, D, Garbarino, L, Locatelli, F, Marenco, P

“…We report on 24 patients with leukemia (19 pts), congenital disorders (4 pts) or severe aplastic anemia (1 pt) who received bone marrow transplantation from…”
Get more information

Allogenic BMT for multiple myeloma (MM). The Italian experience by Cavo, M, Tura, S, Rosti, G, Grimaldi, M, Bandini, G, Bonelli, M A, Calori, E, Rizzi, S, Van Lint, M T, Bacigalupo, A

Get more information

Ciclosporin A: correlation of blood levels with acute graft-versus-host disease after bone marrow transplantation by Bandini, G, Strocchi, E, Ricci, P, Rizzi, S, Boschi, S, Guardigli, C, Calori, E, Motta, M R, Giudice, V, Rosti, G

“…Thirty patients undergoing allogeneic bone marrow transplantation (BMT) for hematologic malignancies received ciclosporin A (CS-A) as prophylaxis of…”
Get more information

Visual Disorders after traumatic brain injury in developmental age by POGGI, G, CALORIE, G, MANCARELLA, G, COLOMBO, E, PROFICE, P, MARTINELLI, F, TRISCARI, C, CASTELLI, E

“…Visual disorders secondary to TBI are common, often multiple, associated with complex clinical pictures; in developmental age they may particularly interfere…”
Get full text